Haemonetics Corp (NYSE:HAE)

69.25
Delayed Data
As of 4:02pm ET
 +0.38 / +0.55%
Today’s Change
37.20
Today|||52-Week Range
72.33
+19.23%
Year-to-Date
International Business Aids NuVasive, Pricing Woe Remains
11:08am / Zacks.com - Paid Partner Content
Luminex (LMNX) Banks on Solid Product Line, Competition Rife
Feb 21 / Zacks.com - Paid Partner Content
5 Top Efficient Stocks to Add to Your Portfolio
9:53am / Zacks.com - Paid Partner Content
Abiomed's Extended FDA Nod for Impella Refines PCI Diagnosis
Feb 16 / Zacks.com - Paid Partner Content
BD (BDX) Launches PAXgene in Europe for Advanced DNA Testing
Feb 21 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Banks on Plasma Franchise, Competition Rife
Feb 12 / Zacks.com - Paid Partner Content
NuVasive's SpineTRACK Registry Gains New CMS Designation
Feb 21 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Hits a 52-Week High: What's Driving It?
Feb 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close68.87
Today’s open69.06
Day’s range68.91 - 70.23
Volume601,279
Average volume (3 months)482,842
Market cap$3.7B
Data as of 4:02pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+53.21%
Earnings growth (this year)+22.06%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)-2.68%
P/E ratioNM
Price/Sales2.36
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.04+0.08%
MMSIMerit Medical System...-0.15-0.33%
INGNInogen Inc+0.13+0.10%
NXTMNxStage Medical Inc-0.25-1.03%
Data as of 4:02pm ET, 02/22/2018

Financials

Last reporting dateFebruary 6, 2018
EPS forecast (this quarter)$0.44
Annual revenue (last year)$886.1M
Annual profit (last year)-$26.3M
Net profit margin-2.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts